MAPT and Alzheimer disease: These results support neuroinflammation and astrogliosis as relevant contributors to Alzheimer's disease pathogenesis, which can be monitored through blood sampling, and suggest neuroinflammation as a potential target for future disease-modifying therapeutic trials targeting tau pathology.